Category - Executive Moves

Executive Moves

Verona Pharma announces senior management changes

Verona Pharma (NASDAQ:VRNA) has appointed David Zaccardelli as president, CEO, and director; and Mark Hahn as CFO. Mr. Zaccardelli will replace current CEO, Jan-Anders Karlsson, who is retiring. Mr. Zaccardelli...

February 3, 2020

Executive Moves

ArcherDX names Mark Massaro as CFO

Closely-held ArcherDX appointed research industry veteran, Mark Massaro, as its CFO. “Mark’s extensive knowledge of the diagnostics landscape, coupled with his more than 20 years of industry experience, is...

January 8, 2020

Executive Moves

Indalo appoints healthcare industry veteran Michael Heffernan as board chair

Closely-held Indalo Therapeutics appointed Michael Heffernan as chair of its board of directors. “Indalo’s unique approach to treating fibrosis, combined with a highly experienced team and world-class financial backers...

December 17, 2019

Executive Moves

Zenabis names Kevin Coft as interim CEO

Zenabis Global (TSX:ZENA) appointed Kevin Coft as interim CEO, effective immediately, replacing Andrew Grieve, whose contract was set to expire shortly. While Mr. Grieve will be returning to his investment business, he...

December 11, 2019

Executive Moves

Gerald Solensky resigns as Zomedica CEO; Shameze Rampertab named interim CEO

Gerald Solensky, Jr. has resigned as CEO, chairman and a director of Zomedica Pharmaceuticals (NYSE American, TSXV:ZOM), effective immediately. He will continue as a consultant to the company’s operating...

December 3, 2019

Executive Moves

Zenabis appoints finance expert Vincent Quan as director

Zenabis Global (TSX:ZENA) appointed Vincent Quan as a director of the company, effective immediately. Mr. Quan has more than 17 years of experience in corporate finance, specializing in the North American agriculture...

November 21, 2019

Executive Moves

Liminal BioSciences names Moira Daniels to head regulatory affairs, quality assurance

Liminal BioSciences (TSX:LMNL; OTCQX:LMNL) appointed Moira Daniels as the new head of regulatory affairs and quality assurance based at the company’s offices in Cambridge, UK. “Moira brings many years of global...

November 13, 2019

Executive Moves

Ventripoint names Justin Leushner as CEO

Ventripoint Diagnostics (TSXV:VPT; OTC:VPTDF) appointed Justin Leushner as CEO, replacing Dr. George Adams, who was elected chairman of the board. Mr. Leushner, who was named president of Ventripoint in September, has a...

November 4, 2019

Executive Moves

Orthofix appoints Jon Serbousek as president and CEO

Orthofix Medical (NASDAQ:OFIX) appointed Jon Serbousek as president, CEO and a director of its board, effective immediately. Mr. Serbousek succeeds Brad Mason, who previously announced his retirement. Mr. Mason has...

November 1, 2019

Executive Moves

Hepion appoints renowned liver disease expert, Dr. Stephen Harrison, as consultant medical director

Hepion Pharmaceuticals (NASDAQ:HEPA) appointed world-renowned Dr. Stephen Harrison as consultant medical director. Dr. Harrison is a peer-reviewer for more than 20 medical journals. He is internationally known for...

October 10, 2019

Category - Executive Moves

Verona Pharma announces senior management changes

ArcherDX names Mark Massaro as CFO

Indalo appoints healthcare industry veteran Michael Heffernan as board chair

Zenabis names Kevin Coft as interim CEO

Gerald Solensky resigns as Zomedica CEO; Shameze Rampertab named interim CEO

Zenabis appoints finance expert Vincent Quan as director

Liminal BioSciences names Moira Daniels to head regulatory affairs, quality assurance

Ventripoint names Justin Leushner as CEO

Orthofix appoints Jon Serbousek as president and CEO

Hepion appoints renowned liver disease expert, Dr. Stephen Harrison, as consultant medical director

Follow Us

General

More

Sign up for the BioTuesdays weekly newsletter